Phio Pharmaceuticals (PHIO) Deferred Taxes (2017)
Phio Pharmaceuticals' (PHIO) quarterly Deferred Taxes came in at -$1.6 million in Q1 2017.
Phio Pharmaceuticals (PHIO) Deferred Taxes (2017) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 1 years of Deferred Taxes data on file, last reported at -$1.6 million in Q1 2017.
- Quarterly Deferred Taxes changed N/A year-over-year to -$1.6 million in Q1 2017, while the trailing twelve-month figure through Dec 2017 was -$1.6 million (changed N/A YoY) and the FY2017 annual result came in at -$1.6 million, changed N/A from the prior year.
- Deferred Taxes held at -$1.6 million in Q1 2017.
- In the past five years, Deferred Taxes ranged from a high of -$1.6 million in Q1 2017 to a low of -$1.6 million in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.66 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Phio Pharmaceuticals | 14.06 Mn | 14.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -1.62 Mn |